Top 2nd-Quarter Buys of Lee Ainslie's Maverick Capital

Dallas-based 'Tiger Cub' reveals portfolio updates

Author's Avatar
Aug 24, 2021
Summary
  • Maverick Capital’s top new buys were Centene, Jones Lang LaSalle and Cano Health.
  • It also added significantly to its Carvana position.
Article's Main Image

Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, recently disclosed the firm’s 13F portfolio changes for the second quarter of 2020, which ended on June 30.

One of the “Tiger Cubs” mentored by legendary investor Julian Robertson (Trades, Portfolio) of Tiger Management, Ainslie founded Maverick Capital in 1993. The Dallas-based firm employs six industry heads for researching investment opportunities, each one an expert in their respective industry: consumer, health care, cyclical, retail, financial and telecommunications/media/technology. After consulting these experts, Ainslie makes the final call on any changes to the portfolio.

As per its latest 13F filing, Maverick Capital’s top buys for the quarter were for Centene Corp. (CNC, Financial), Jones Lang LaSalle Inc. (JLL, Financial), Cano Health Inc. (CANO, Financial) and Carvana Co. (CVNA, Financial).

Centene

The firm acquired a new stake worth 3,416,815 shares in Centene Corp. (CNC, Financial), giving the stock a 2.34% weight in the equity portfolio. During the quarter, shares traded for an average price of $68.44.

1430239973256204288.png

Based in St. Louis, Centene is a major intermediary for both government-sponsored and privately insured health care programs in the U.S. It focuses on managed care for uninsured, underinsured and low-income individuals.

On Aug. 24, shares of Centene traded around $64.90 for a market cap of $37.77 billion. According to the GuruFocus Value chart, the stock is modestly undervalued.

1430247011952627712.png

The company has a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10. The interest coverage ratio is low at 3.98, but the Piotroski F-Score of 5 out of 9 is typical of a financially stable company. The company has a three-year revenue per share growth rate of 11.9% and a three-year Ebitda growth rate of 18.4%.

1430248048834908160.png

Jones Lang LaSalle

The firm established an 878,381-share holding in Jones Lang LaSalle (JLL, Financial), giving the investment a 1.61% weight in the equity portfolio. Shares traded for an average price of $194.99 during the quarter.

1430240547297038336.png

Based in Chicago, Jones Lang LaSalle is a commercial real estate company that also provides a range of investment management services. It buys, builds and invests in a variety of assets ranging from real estate to banking and technology.

On Aug. 24, shares of Jones Lang LaSalle traded around $239.82 for a market cap of $12.17 billion. According to the GF Value chart, the stock is significantly overvalued.

1430253921095389184.png

The company has a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10. The Piotroski F-Score of 6 out of 9 and Altman Z-Score of 2.99 represent a stable financial situation. The return on invested capital (ROIC) has been lower than the weighted average cost of capital (WACC) in recent years, meaning the company is not creating value as it grows.

1430255046804639744.png

Cano Health

Another new holding for the firm is Cano Health (CANO, Financial); during the quarter, Maverick Capital acquired 8,354,601 shares of this stock, giving it a 0.90% weight in the equity portfolio. During the quarter, shares traded for an average price of $13.01.

1430241928334544896.png

Cano Health is a leading provider of health care services for seniors in the U.S., serving both Medicare and Medicaid patients. The Wilmington, Delaware-based company operates primary care centers and supports affiliated medical practices that specialize in primary care for seniors.

On Aug. 24, shares of Cano Health traded around $11.68 for a market cap of $2.02 billion. Since going public this past June, shares have dropped 20%.

1430255452586774528.png

The company has a financial strength rating of 4 out of 10 and a profitability rating of 1 out of 10. The cash-debt ratio of 0.6 is low, but the current ratio of 5.1 indicates the company can at least keep paying its debts in the short term. The operating margin of 0.77% and net margin of 2.41% indicate the company could become profitable soon.

1430256424767721472.png

Carvana

In the first quarter of 2021, Maverick Capital had a nominal holding of only 509 shares in Carvana (CVNA, Financial), but in the second quarter, it increased this investment by 311,395 shares, or 61,177.8%, for a total of 311,904 shares. The trade had a 0.88% impact on the equity portfolio. Shares traded for an average price of $271.66 during the quarter.

1430242551935275008.png

Carvana is an e-commerce company that sells used cars through its unique technology platform, which aims to make the used car buying process easier and faster. Founded in 2012, the Tempe, Arizona-based company is a relatively new market player that has been rapidly growing its top line.

On Aug. 24, shares of Carvana traded around $354.79 for a market cap of $61.23 billion. According to the GF Value chart, the stock is significantly overvalued.

1430256864880234496.png

The company has a financial strength rating of 3 out of 10 and a profitability rating of 2 out of 10. The cash-debt ratio of 0.06 and Piotroski F-Score of 3 out of 9 indicate poor business operation. The operating margin and net margin have both turned positive as of the most recent quarter, reaching 2.46% and 0.66%, respectively.

1430257283241086976.png

Portfolio overview

As of the quarter’s end, the firm held 662 common stock positions valued at a total of $10.65 billion. The top holdings were Coupang Inc. (CPNG, Financial) with 42.35% of the equity portfolio, Microsoft Corp. (MSFT, Financial) with 2.48% and Centene with 2.34%.

1430234098734993408.png

In terms of sector weighting, the firm was most invested in consumer cyclical, followed by health care and technology.

1430234354923081728.png

Disclosures

I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours. Click for the complete disclosure